Citicoline (sodium)

• Description :

  Citicoline sodium is an endogenous intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes. Citicoline sodium inhibits reactive oxygen species (ROS) and apoptosis. Citicoline sodium can be used for neurological disease and hearing loss study[1][2][3].

• Product Name Alternative :

  Cytidine diphosphate-choline (sodium) ; CDP-Choline (sodium) ; Cytidine 5'-diphosphocholine (sodium)

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Apoptosis; Caspase; Endogenous Metabolite; Reactive Oxygen Species (ROS)

• Type :

  Natural Products

• Related Pathways :

  Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Cancer; Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/Cytidoline_sodium_salt.html

• Purity :

  99.60

• Solubility :

  DMSO : < 1 mg/mL|H2O : ≥ 100 mg/mL

• Smiles :

  NC(C=CN1[C@H]2[C@H](O)[C@H](O)[C@@H](COP(OP(OCC[N+](C)(C)C)([O-])=O)(O[Na])=O)O2)=NC1=O

• Molecular Formula :

  C14H25N4NaO11P2

• Molecular Weight :

  510.31

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Davinelli S, et al. Cytoprotective Effects of Citicoline and Homotaurine against Glutamate and High Glucose Neurotoxicity in Primary Cultured Retinal Cells. Oxid Med Cell Longev. 2017;2017:2825703.|[2]Karpova MN, et al. Increase of the seizure threshold in C57BL/6 mice after citicoline administration. Bull Exp Biol Med. 2015 Jan;158 (3) :315-7.|[3]Zhong Z, et al. Citicoline Protects Auditory Hair Cells Against Neomycin-Induced Damage. Front Cell Dev Biol. 2020 Aug 31;8:712.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, sealed storage, away from moisture)

• Scientific Category :

  Natural Products

• Clinical Information :

  Launched

• Isoform :

  Caspase 3; Caspase 8; Caspase 9; Human Endogenous Metabolite; Microbial Metabolite

• Citation 01 :

  Int J Biol Macromol. 2025 Jan 5:139536.|bioRxiv. 2025 April 09.|Nat Neurosci. 2023 Apr;26 (4) :542-554.|Patent. US20240269160A1.

• CAS Number :

  [33818-15-4]